Literature DB >> 11562962

Purification of PMPA amidate prodrugs by SMB chromatography and x-ray crystallography of the diastereomerically pure GS-7340.

H Chapman1, M Kernan, J Rohloff, M Sparacino, T Terhorst.   

Abstract

The diastereomers of GS-7171, aryl phosphoramidate derivatives of the anti-HIV nucleotide analog 9-[2-R-(phosphonomethoxy)propyl]adenine (tenofovir, PMPA), were isolated by batch elution chromatography and continuous simulated moving bed chromatography. The absolute configuration of the more pharmacologically active diastereomer, GS-7340, was determined to be (R,S,S) by single crystal x-ray crystallography.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562962     DOI: 10.1081/NCN-100002495

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  8 in total

1.  Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes.

Authors:  Duncan T Njenda; Shambhu G Aralaguppe; Kamalendra Singh; Rohit Rao; Anders Sönnerborg; Stefan G Sarafianos; Ujjwal Neogi
Journal:  J Antimicrob Chemother       Date:  2018-10-01       Impact factor: 5.790

2.  Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.

Authors:  Kathy A Keith; Michael J M Hitchcock; William A Lee; Antonin Holý; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 3.  An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014.

Authors:  Erik De Clercq
Journal:  Acta Pharm Sin B       Date:  2015-11-02       Impact factor: 11.413

Review 4.  Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.

Authors:  Magdalena Slusarczyk; Michaela Serpi; Fabrizio Pertusati
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec

Review 5.  Harnessing nanostructured systems for improved treatment and prevention of HIV disease.

Authors:  Maya Monroe; Charles Flexner; Honggang Cui
Journal:  Bioeng Transl Med       Date:  2018-07-27

6.  Improving the solubility and bioavailability of anti-hepatitis B drug PEC via PEC-fumaric acid cocrystal.

Authors:  Long Li; Xian-Hong Yin; Kai-Sheng Diao
Journal:  RSC Adv       Date:  2020-10-02       Impact factor: 4.036

Review 7.  Approved HIV reverse transcriptase inhibitors in the past decade.

Authors:  Guangdi Li; Yali Wang; Erik De Clercq
Journal:  Acta Pharm Sin B       Date:  2021-11-16       Impact factor: 14.903

8.  Synthesis and Evaluation of Biological Activity of New Arylphosphoramidates.

Authors:  Amal Thebti; M A K Sanhoury; H-I Ouzari; T Barhoumi-Slimi
Journal:  Biomed Res Int       Date:  2018-08-26       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.